NEW YORK ( TheStreet) -- C.R. Bard (NYSE: BCR) hit a new 52-week high Thursday as it is currently trading at $104.94, above its previous 52-week high of $104.90 with 96,046 shares traded as of 10:26 a.m. ET. Average volume has been 693,800 shares over the past 30 days.

C.R. Bard has a market cap of $8.9 billion and is part of the health care sector and health services industry. Shares are up 13.6% year to date as of the close of trading on Wednesday.

C. R. Bard, Inc., together with its subsidiaries, engages in the design, manufacture, packaging, distribution, and sale of medical, surgical, diagnostic, and patient care devices worldwide. It offers vascular, urology, oncology, and surgical specialty products. The company has a P/E ratio of 18.5, below the average health services industry P/E ratio of 19.4 and above the S&P 500 P/E ratio of 16.9.
  • Practice your BCR trading strategies and win cash in our stock game.

TheStreet Ratings rates C.R. Bard as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, expanding profit margins and increase in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. You can view the full C.R. Bard Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.